4//SEC Filing
Ellison Mark Jason Heath 4
Accession 0001385508-23-000067
CIK 0001385508other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:16 AM ET
Size
17.8 KB
Accession
0001385508-23-000067
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Common Stock
2023-03-02$20.00/sh−7,015$140,300→ 11,736 total - Disposition to Issuer
Common Stock
2023-03-02$20.00/sh−11,736$234,720→ 0 total - Disposition to Issuer
Common Stock
2023-03-02$20.00/sh−9,680$193,600→ 0 total(indirect: See Footnote (1)) - Award
Common Stock
2023-03-02+2,000→ 2,000 total - Disposition to Issuer
Common Stock
2023-03-02−7,200→ 0 totalExercise: $13.61From: 2019-02-03Exp: 2029-01-02→ Common Stock (7,200 underlying) - Disposition to Issuer
Common Stock
2023-03-02−8,250→ 0 totalExercise: $13.60Exp: 2030-01-07→ Common Stock (8,250 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-03-02−10,750→ 0 totalExercise: $12.15Exp: 2031-01-26→ Common Stock (10,750 underlying) - Disposition to Issuer
Common Stock
2023-03-02$20.00/sh−2,000$40,000→ 0 total
Footnotes (4)
- [F1]Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Indivior Inc., and Olive Acquisition Subsidiary, Inc., dated as of November 13, 2022 (the "Merger Agreement"), in exchange for a cash payment of $20.00 per share without interest thereon (the "Merger Consideration").
- [F2]Disposed of pursuant to the Merger Agreement in exchange for the Merger Consideration. The number of shares disposed of reflects 11,736 shares of Common Stock upon the acceleration of vesting of restricted stock units in accordance with the Merger Agreement.
- [F3]2,000 shares are represented by performance stock units ("PSUs"), the vesting of which accelerated in accordance with the Merger Agreement. Each PSU represents the Reporting Person's right to receive one share of Common Stock of Issuer.
- [F4]The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001781982
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:16 AM ET
- Size
- 17.8 KB